Abstract

Antiphospholipid syndrome (APS) is an autoimmune disorder, characterized by venous or arterial thromboembolism, and obstetric morbidities in the presence of persistently positive levels of antiphospholipid antibodies, which could be recognized on two different occasions separated 12 weeks apart.1,2 APS is a relative rare but potentially lethal disease, and the clinical presentation could be highly variable.3 Due to lack of large population-based investigation, the true prevalence of APS is unknown and is estimated to be about 40 to 50 cases per 100,000 persons. The incidence of APS is estimated to be 5 cases per 100,000 person-years.4 Patients with APS are at increased risk of vascular atherosclerosis, myocardial infarction, stroke, and valvular heart disease.5 Consequently, anticoagulant is recommended among patients with APS. The detection of APS depends on high sense of suspicion and alertness. In the current report, we describe a case of APS with transient visual loss and recurrent myocardial infarction.
Original languageEnglish
Pages (from-to)664-667
Number of pages4
JournalActa Cardiologica Sinica
Volume37
Issue number6
DOIs
Publication statusPublished - Nov 1 2021

Cite this